Urigen Pharmaceuticals
Wilmington
About Urigen Pharmaceuticals
Urigen specializes in the design and implementation of innovative products for patients with urological ailments including, specifically, the development of innovative products for amelioration of Painful Bladder Syndrome (PBS), Urethritis, Nocturia and Over Active Bladder (OAB).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $9.1M
- Last round: Series Unknown (Jan 2024)
- Website: urigen.com
- Phone: 925-280-2861
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/urigen-pharmaceuticals-20706 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.